Adriana Haralson
Physician Assistant · Maitland, FLNPI 1245788967
Payments from drug & device makers
Across 383 payments — averaging $21.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$981
- Bayer$791
- Lilly USA, LLC$643
- Boehringer Ingelheim$611
- Novo Nordisk$548
- plus $4K from 33 others
What the payments were for
- Food & beverage$8,423100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $1,016 |
| AbbVie | 44 | $981 |
| Bayer | 30 | $791 |
| Lilly USA, LLC | 38 | $643 |
| Boehringer Ingelheim | 28 | $611 |
| Novo Nordisk | 29 | $548 |
| Pfizer | 26 | $455 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $434 |
| Sanofi-aventis U.S. LLC | 21 | $382 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $323 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $265 |
| Corcept Therapeutics | 5 | $210 |
| Amgen | 11 | $197 |
| Merck | 9 | $166 |
| Exact Sciences | 8 | $163 |
| Abbott | 7 | $150 |
| Phathom Pharmaceuticals, Inc. | 1 | $139 |
| GSK | 9 | $136 |
| Lexicon Pharmaceuticals, Inc. | 1 | $125 |
| Esperion Therapeutics, Inc. | 2 | $85 |
| Edwards Lifesciences | 3 | $85 |
| Novartis | 4 | $68 |
| Dexcom, Inc. | 3 | $56 |
| Xeris Pharmaceuticals, Inc. | 2 | $48 |
| Johnson & Johnson | 3 | $46 |
| Idorsia Pharmaceuticals US Inc | 2 | $38 |
| Radius Health, Inc. | 2 | $33 |
| Sanofi Pasteur Inc. | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Biohaven Pharmaceuticals, Inc. | 2 | $24 |
| Corium, LLC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $18 |
| Sanofi | 1 | $16 |
| Lifescan, Inc. | 1 | $14 |
| Mylan Specialty L.p. | 1 | $14 |
| Nevro Corp. | 1 | $13 |
| GRT US Holding, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,423 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 78 | $84,824 |
| MounjaroTirzepatide | 73 | $78,416 |
| JardianceEmpagliflozin | 63 | $74,818 |
| EliquisApixaban | 49 | $69,002 |
| FarxigaDapagliflozin Propanediol | 66 | $67,306 |
| Nurtec OdtRimegepant Sulfate | 26 | $51,846 |
| XifaxanRifaximin | 11 | $34,656 |
| ProliaDenosumab | 17 | $30,715 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $27,945 |
| LinzessLinaclotide | 25 | $27,076 |
| TrulicityDulaglutide | 27 | $26,412 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 38 | $25,022 |
| VraylarCariprazine Hcl | 13 | $24,167 |
| JanuviaSitagliptin Phosphate | 16 | $23,510 |
| KerendiaFinerenone | 12 | $21,666 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Nurtec Odt | $455 | $120,84775 claims |
| Lilly USA, LLCMounjaro, Trulicity | $643 | $104,827100 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,016 | $102,487145 claims |
| Novo NordiskOzempic | $548 | $84,82478 claims |
| Boehringer IngelheimJardiance | $611 | $74,81863 claims |
| AbbVieLinzess, Vraylar, Qulipta | $981 | $72,17057 claims |
| MerckJanuvia, Janumet Xr | $166 | $37,52929 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $136 | $33,67246 claims |
| AmgenProlia | $197 | $30,71517 claims |
| BayerKerendia | $791 | $21,66612 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $382 | $17,13616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Maitland
- Reeli ReinuMaitland$427K
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.